Robert E. Landry joined Regeneron in 2013 and serves as executive vice president, finance and chief financial officer. Prior to Regeneron, Dr. Akinlade held medical director roles of increasing seniority at Astellas Pharma and Abbott Laboratories (now AbbVie). Takeda in International Relations from the University of Delaware. Salary.com's CompAnalyst platform offers: These charts show the average base salary (core compensation), as well as the average total cash compensation for Vice President of Laboratory in companies like REGENERON PHARMACEUTICALS, INC. in the United States. Neil Stahl, Ph.D., joined Regeneron in 1991 and has served as executive vice president, research and development since January 2015. Prior to joining Regeneron, Ms. Tegan worked at Ciba Specialty Chemicals and then as senior director/head of procurement at Purdue Pharma L.P., where she held roles of increasing responsibility. Other. in biology from the University of Science and Technology of China and his Ph.D. in cell biology from the University of Washington. He has served as chief executive officer of GanD, Inc. since 2016, and chair of Grace Science, LLC since 2017. He served as president and chief executive officer of Memorial SloanKetteringCancer Center (MSK) from 2010 until September 2022 and continues to oversee the Craig Thompson Lab, which studies cellular metabolism and its role in disease. Mr. Brooks leads a team responsible for optimizing liquidity and use of capital resources, safeguarding Regenerons cash and investment portfolio, corporate risk management and maintaining strong relationships with financial institutions, insurance providers and rating agencies. At Regeneron, we believe in the power of original thinking. This report is not for commercial use. He completed his post-doctoral studies at the University of Pennsylvania. Maya Bermingham, J.D., joined Regeneron in 2015 and serves as senior vice president, public policy and government affairs. Mr. LaRosa received his J.D. from Virginia Polytechnic Institute and State University. He earned a M.S. Wenn Salaries at Regeneron range from an average of $52,000 to $139,000 a year. Gregory Geba, M.D., Ph.D., joined Regeneron in 2013 and serves as senior vice president of the global development scientific council, a group that provides senior scientific input to Regenerons therapeutic portfolio of programs. In addition, his team oversees regulatory functions including labeling and advertising/promotion and compliance. Senior Vice President, Technical Operations. in biotechnology from Dublin City University, Ireland and his MBA from the Williams College of Business at Xavier University in Cincinnati, Ohio. Executive Vice President and General Manager, Industrial Operations and Product Supply. In addition to managing the Human Resources Department, the Director serves as the executive staffonline to the attention of Dele Lowman Smith, Senior Vice President, 630 Dundee Road, #130 Electra Aero - Manassas Niall OLeary joined Regeneron in 2012 and serves as senior vice president and site head of IOPS Raheen. Dr. Schleifer, together with Regenerons founding scientist, Dr. Yancopoulos, built and managed the company over the past 35 years. Snow built his expertise at various pharmaceutical and healthcare companies including AstraZeneca, Bristol Myers Squibb, Eloxx Pharmaceuticals and Radius Health. Aydanos a proteger Glassdoor y demustranos que eres una persona real. Prior to joining Regeneron, Dr. Lancaster served as chief medical officer at Myriad Genetics, Inc., following more than a decade in academics at Moffitt Comprehensive Cancer Center in Tampa as a gynecologic oncologist, molecular genetics researcher, and ultimately President of the Moffitt Medical Group Corporation. Dr. Zambrowicz received his B.S. She also held a number of roles within Novartis Oncology, including head of U.S. ethics, risk & compliance, head of global integrity & compliance, ad interim, and senior legal counsel. He completed his medical residency at North Shore Long Island Jewish (LIJ) Health System and conducted post doctorate work at Columbia University. Dr. Yancopoulos, together with key members of his team, is a principal inventor and/or developer of the nine FDA-approved drugs Regeneron has developed: EYLEA (aflibercept) Injection, Praluent (alirocumab), Dupixent (dupilumab), Kevzara (sarilumab), Libtayo (cemiplimab), EvkeezaTM (evinacumab-dgnb), Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn), ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST (rilonacept) Injection for Subcutaneous Use, as well as Regeneron's foundation technologies, including the TRAP technology, VelociGene and VelocImmune. Benjamin Yocum joined Regeneron in 2000 and serves as senior vice president, manufacturing operations. Ms. Poon has been a director of the company since 2010. Know Your Worth. Smita Pillai joined Regeneron as our first chief diversity, equity and inclusion (DEI) officer in 2021. Prior to joining Fisher, Ms. Poon was vice chair, worldwide chair of pharmaceuticals, member of the executive committee and director at Johnson & Johnson. , from Hibernia College. VA. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. Deborah Tegan joined Regeneron in 2006 and serves as senior vice president, strategic sourcing and procurement. Chris Fenimore joined Regeneron in 2003 and, as the current head of accounting and controller, has global responsibility for SEC reporting,accounting and accounting operations, and internal control over financial reporting, administration of financial systems, accounts payableandpayroll. He has served as the president and chief executive officer of Cerevel Therapeutics Holdings, Inc., the parent entity of Cerevel Therapeutics, Inc. since 2019, and as chair of Cerevel Therapeutics Holdings, Inc. since 2018. The charts on this page feature a breakdown of the total annual pay for the top executives at REGENERON PHARMACEUTICALS, INC. as reported in their proxy statements. The estimated base pay is $206,839 per year. He holds a BBA in accounting from the University of Notre Dame. The average salary for a Vice President is $172,519 per year in United States, which is 59% lower than the average Regeneron salary of $420,792 per year for this job. He served as executive vice president and chief scientific officer at Genentech, Inc. from 2003 to 2011. Highest reported salary offered at Regeneron Pharmaceuticals is $172k. Prior to joining Regeneron, Mr. Yocum worked within the Chemistry Department at Seattle Pacific University. Onze However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement. Previously, he served as president of The Rockefeller University and Carson Family Professor and head of the Laboratory of Brain Development at The Rockefeller University from 2011 to 2016. Related Searches:All Vice President Salaries|All Regeneron Salaries. Regeneron and Vertex board members rake in highest pay in the S&P 500 Prior to Regeneron, Mr. Carreau worked at Novartis (formerly Chiron Corporation). from the University of Rochester and a Ph.D. from State University of New York. Merck at New York Medical College and a Ph.D. from Saint Johns University. Before joining Regeneron, Mr. Underwood worked at Fluor Daniel, the Jacobs Engineering Group and Day Laboratories. Senior Vice President, IOPS Finance and Business Operations. Takeda from New York University. AstraZeneca Human Resources Vice President Salaries in - Glassdoor Goldstein and Brown jointly received the Nobel Prize for Physiology or Medicine in 1985 and the U.S. National Medal of Science in 1988. She was previously executive vice president, chief human resources ocer at Inova Health System. He received his B.S. $2.8M. He co-founded Agios Pharmaceuticals and previously served as a director of Merck and Charles River Laboratories. REGENERON PHARMACEUTICALS Division Vice President of Sales and Prior to joining Regeneron, Dr. Stahl received his B.S. Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle. #bestplacetowork #careers, The average Regeneron salary ranges from approximately $52,103 per year for, Regeneron employees attributed a compensation and benefits rating of 4.2/5 stars to their company. Regeneron's people make us who we are, and we are truly more than a company - we're a community. Read what they think about their salaries on our Compensation FAQ page for Regeneron. Before joining the pharmaceutical industry, Dr. Hughes worked as a medical practitioner in the UK and U.S. Dr. Hughes earned a medical degree (MBBS) from The Royal Free Hospital and School of Medicine, London University, and an M.Sc. Prior to joining Regeneron, Dr. Baras contributed to other biotechnology ventures and conducted research spanning antibody-based therapeutics, cancer research and nanotechnology applications in drug development. Scribe Therapeutics - Alameda Executive Vice President, General Counsel and Secretary. Director, Biostatistics - Regeneron Pharmaceuticals, Inc. She received a J.D. Regeneron Perspectives Advancing our commitment to diversity, equity & inclusion Fostering inclusion in our workplace and communities is a natural extension of our mission to improve lives Maya Bermingham, Interim Head of DE&I; Vice President, Government Affairs and Public Policy October 2, 2020 Prior to his time at MSK,Dr. Thompsonmade significant contributions to cancer research as a physician and clinical investigator. in international relations and Chinese from Tufts University. Johnathan M. Lancaster, M.D., Ph.D., joined Regeneron in 2019 as a vice president and now serves as SVP and head of global medical affairs. Thank you to our incredible colleagues for making this truly a great place to work and a place where passion meets opportunity. The estimated base pay is $208,589 per year. from the University of Navarra, completed a fellowship in immunology/pulmonary and critical care at Yale University, received an MPH. It is especially meaningful that this award is based in part on the quality and consistency of employee reviews on Glassdoor. Kerry Reinertsen, Ph.D., joined Regeneron in 2011 and serves as senior vice president of strategic alliances. He received his B.S. Our model gets smarter over time as more people share salaries on Glassdoor. William Olson, Ph.D., joined Regeneron in 2013 as vice president and now serves as senior vice president of therapeutic proteins, where he is responsible for antibody generation, a key component of drug discovery, through innovative technologies. from SUNY Stony Brook, a M.S. REGENERON PHARMACEUTICALS, INC. Vice President of Laboratory Salary COMPANY SIZE 5,000 to 9,999 employees INDUSTRY Biotechnology/Pharmaceuticals FOUNDED 1988 WEBSITE https://www.regeneron.com/ Similar Jobs Respiratory Therapist - PRN - Ardmore Mercy Ardmore, OK 11 days ago Apply RRT Focus Staff Ardmore, OK 8 days ago VA. Job TitleVice President, Talent and LearningOverviewAccountable for developing and delivering andmember of the Global Talent and OE Leadership TeamAll About You Experience in HR Business City of Virginia Beach - Virginia Beach Senior Manager, Workforce Planning & Engagement - LinkedIn Senior Vice President, Early Clinical Development and Experimental Sciences. Executive Vice President, Human Resources. Regeneron Pharmaceuticals Inc H1B Salary 2020 124 records was found, Median Salary is $126250. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. Thorough reviews have been conducted to assure this data accurately reflects disclosures. During her tenure, Dr. Morton has established cardiovascular, renal and fibrosis research at Regeneron. Biogen How much do Regeneron employees make? at Saint Johns University. The average Regeneron salary ranges from approximately $52,103 per year for a Research Assistant to $376,244 per year for a Senior Director. Andrew Murphy, Ph.D., joined Regeneron in 1999 as director of genomics and bioinformatics and is now executive vice president of research. George D. Yancopoulos, MD, PhD Co-Founder, President and Chief Scientific Officer View bio Corporate Leaders Zoran Berkovic Senior Vice President, Financial Planning and Analysis View bio Maya Bermingham Senior Vice President, Public Policy and Government Affairs View bio Christina Chan Nouhad Husseini joined Regeneron in 2011 and is head of business development, overseeing the companys efforts to execute new strategic collaborations and licensing agreements. She oversees global HR systems and processes and is expanding HR operations to support employees in a growing number of countries outside the U.S. Dr. Tessier-Lavigne is also a member of the board of directors of Denali Therapeutics Inc. President Emeritus of Memorial SloanKettering Cancer Center. Prior to his current role, he served as Regenerons vice president of financial planning, and prior to joining Regeneron, he was vice president of finance at Mojave Therapeutics, Inc. Mr. Yocums broad knowledge and expertise in Good Manufacturing Practices (GMP) and processes have contributed to the successful launch of every Regeneron commercial product. Executive Vice President, Functional Genomics and Chief VelociGene Operations. , Gilead Regeneron Pharmaceuticals: Delivering Life-transforming Medicines He was also a professor at Stanford University from 2001 to 2003 and at the University of California, San Francisco from 1991 to 2001. Job - The hired Accounting VP will lead a global accounting team of 20+, with 5-6 direct reports. He has driven an enhanced company focus on big data, innovation and strategic IT investments that support Regenerons mission. Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. Andrew J. Murphy Ph.D. - Salary.com Highest Paying Job At Regeneron In Rensselaer, NY Medical Director - $261,089 See Other Titles Highest Paying Department At Regeneron In Rensselaer, NY $115,622 See Other Departments Mr. Brooks received both a B.S. Prior to that she was chief diversity officer for Dow Jones, including its flagship brand, The Wall Street Journal. Compensation Information for Daniel Van Plew, Executive Vice President
